CEL-SCI reports net loss of $2.

R&D expenses increased due to the increased level of activity connected with conducting the Business's Phase III clinical study. THE BUSINESS ended the December one fourth with approximately $10,736,000 in cash and cash equivalents. During the quarter, the ongoing organization completed a Registered Direct financing, producing net proceeds of $9,807,000. Geert Kersten, Chief Executive Officer said, We continue steadily to make significant improvement inside our pivotal global Stage III clinical trial of Multikine .Dermagenics Ultra-Intensive Anti-Wrinkle Beauty Moisturizer is gentle enough at under the optical eyes, yet powerful more than enough for the facial skin and neck, thereby ridding the need for multiple serums and creams for different pores and skin sites. Designed for night and day use, it contains powerful natural ingredients and the latest patented anti-maturing discoveries. Dermagenics was lately rated among the top five anti-wrinkle creams available by a scientifically structured, independent skin-care business. New Beauty Magazine defined Dermagenics as ‘just one of those uncommon finds whose praises ought to be sung.’ Dermagenics may be the perfect gift for occupied executives, travelers, and moms as well who all would welcome a streamlined, convenient skin-care product that effectively replaces pricey, complicated skin-treatment regiments.